Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes

NCT05232630 is registered in ClinicalTrials.gov with Hospital Ruber Internacional as lead sponsor.

NCT NCT05232630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05232630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
Lead sponsor
Hospital Ruber Internacional
Phase
Phase 4
Overall status
Completed
Start date
October 20, 2022
Completion date
December 31, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

continuous spike and waves during slow sleep, inv dup(15) encephalopathy, multifocal or bilateral malformations of cortical development, refractory epilepsy, stxbp1 encephalopathy with epilepsy, syngap1 encephalopathy